银伤口敷料市场机会、成长动力、产业趋势分析及 2024 年至 2032 年预测

在慢性伤口病例增加、手术增加和伤口护理创新的推动下，2023 年全球银伤口敷料市场价值将达到 10 亿美元，预计 2024 年至 2032 年复合年增长率将超过 5.8%。伤口护理技术的进步，特别是水胶体、泡沫和藻酸盐类型等银基敷料的进步，增强了抗菌效果和保湿性，营造了最佳的癒合环境。这些创新也提高了患者的舒适度并简化了应用，进一步推动了市场成长。

由于糖尿病和行动不便等疾病，老年人口不断增加，慢性损伤和溃疡的风险更高，这刺激了对银伤口敷料的需求。该市场的产品类型包括片材、凝胶和霜、泡沫等。银敷料片在 2023 年的价值为 3.679 亿美元，由于其广泛的抗菌覆盖范围、易于使用和持久的效果而引领市场，使其成为慢性伤口护理的理想选择。这些床单的最新发展，如受控银离子释放和多层设计，进一步改善了卫生和气味控制，支持了他们对伤口处理日益增长的偏好。

最终用户部分包括医院和诊所、门诊手术中心和家庭护理机构，到2023 年，医院和诊所的销售额将达到5.277 亿美元。復健併发症并简化高成本流程。这种采用符合临床指南，强调银敷料在复杂伤口处理中的功效，支持市场扩张。

银色伤口敷料市场按适应症细分，包括手术伤口、烧伤、溃疡、撕裂伤和割伤、皮肤移植等伤口类型。 2023 年，手术伤口领域占据了 31.3% 的市场份额，这主要是由于全球与生活方式疾病、创伤和择期手术相关的手术数量增加。随着这一趋势，对先进伤口护理解决方案（包括银敷料）的需求也在增加。

美国市场将以5.7% 的复合年增长率成长，到2032 年将达到6.666 亿美元。特别是在术后感染。美国疾病管制与预防中心 (CDC) 和美国食品药物管理局 (FDA) 对减少抗生素依赖和使用抗菌敷料的认可增强了人们对银基伤口护理产品的偏好，推动了市场成长。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 慢性伤口和外科手术的发生率增加
    • 伤口护理技术的进步
    • 烧伤和外伤病例增加
    • 对先进伤口护理解决方案的认识和偏好不断提高
  • 产业陷阱与挑战
    • 替代治疗的可用性
    • 细胞毒性风险
• 成长潜力分析
• 监管环境
• 未来市场趋势
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司市占率分析
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品类型，2021 - 2032 年

• 主要趋势
• 床单
• 凝胶和乳霜
  • 海藻酸盐
  • 水凝胶
  • 磺胺嘧啶银
  • 其他凝胶和乳霜
• 泡棉
• 其他产品类型

第 6 章：市场估计与预测：按指标划分，2021 - 2032 年

• 主要趋势
• 手术伤口
• 伯恩斯
• 溃疡
• 割伤和割伤
• 皮肤移植
• 其他适应症

第 7 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 医院和诊所
• 门诊手术中心
• 家庭护理设置

第 8 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中东和非洲
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 9 章：公司简介

• 3M Company
• Advanced Medical Solutions Group
• B Braun Melsungen
• Bravida Medical
• Convatec
• Coloplast
• DermaRite Industries
• Ethicon (Johnson and Johnson)
• Ferris Mfg
• Medline Industries,
• Monlycke Health Care
• Smith & Nephew

The Global Silver Wound Dressing Market, valued at USD 1 billion in 2023, is projected to grow at a CAGR exceeding 5.8% from 2024 to 2032, driven by rising chronic wound cases, an increase in surgeries, and innovations in wound care. Advancements in wound care technology, particularly in silver-based dressings such as hydrocolloid, foam, and alginate types, enhance antimicrobial effectiveness and moisture retention, fostering an optimal healing environment. These innovations also boost patient comfort and simplify applications, further propelling market growth.

The growing elderly population, at higher risk of chronic injuries and ulcers, owing to conditions like diabetes and reduced mobility, fuels the demand for silver wound dressings. Product types in this market include sheets, gels & creams, foams, and more. Silver dressing sheets, valued at USD 367.9 million in 2023, lead the market due to their extensive antimicrobial coverage, ease of use, and long-lasting effects, making them ideal for chronic wound care. Recent developments in these sheets, like controlled silver ion release and multi-layered designs, further improve hygiene and odor control, supporting their rising preference in wound management.

The end-user segment comprises hospitals & clinics, ambulatory surgical centers, and home care settings, with hospitals & clinics dominating at USD 527.7 million in 2023. Hospitals increasingly adopt silver dressings to mitigate risks associated with SSIs, reduce recovery complications, and streamline high-risk wound care protocols. This adoption aligns with clinical guidelines, which emphasize the efficacy of silver dressings in complex wound management, supporting market expansion.

The silver wound dressing market, segmented by indication, includes surgical wounds, burns, ulcers, lacerations and cuts, skin grafts, and other wound types. In 2023, the surgical wounds segment held a significant 31.3% market share, largely due to a global increase in surgeries related to lifestyle diseases, trauma, and elective procedures. Demand for advanced wound care solutions, including silver dressings, has risen alongside this trend.

The U.S. market is set to grow at a 5.7% CAGR, reaching USD 666.6 million by 2032. The high incidence of hospital-acquired infections (HAIs) is a significant driver, as silver wound dressings are widely used in infection prevention, especially in post-operative care. Endorsements from the CDC and U.S. FDA to reduce antibiotic reliance and use antimicrobial dressings bolster the preference for silver-based wound care products, fueling market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing incidence of chronic wounds and surgical procedures
    • 3.2.1.2 Advancement in wound care technology
    • 3.2.1.3 Increase in burn injuries and trauma cases
    • 3.2.1.4 Rising awareness and preference for advanced wound care solutions
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Availability of alternative treatment
    • 3.2.2.2 Risk of cytotoxicity
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Future market trends
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Sheets
• 5.3 Gels & creams
  • 5.3.1 Alginate
  • 5.3.2 Hydrogel
  • 5.3.3 Silver sulfadiazine
  • 5.3.4 Other gels & creams
• 5.4 Foams
• 5.5 Other product types

Chapter 6 Market Estimates and Forecast, By Indication, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Surgical wounds
• 6.3 Burns
• 6.4 Ulcers
• 6.5 Lacerations and cuts
• 6.6 Skin grafts
• 6.7 Other indications

Chapter 7 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Hospitals & clinics
• 7.3 Ambulatory surgical centers
• 7.4 Homecare settings

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
• 8.6 Middle East and Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 3M Company
• 9.2 Advanced Medical Solutions Group
• 9.3 B Braun Melsungen
• 9.4 Bravida Medical
• 9.5 Convatec
• 9.6 Coloplast
• 9.7 DermaRite Industries
• 9.8 Ethicon (Johnson and Johnson)
• 9.9 Ferris Mfg
• 9.10 Medline Industries,
• 9.11 Monlycke Health Care
• 9.12 Smith & Nephew